Supplementary Figure 9 from Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
crossref（2023）
摘要
PDF file - 24K, HER2/Neu antibody and TCN plus anti-CTLA-4 mAb triple combination treatment increased serum IFN-gamma level
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要